Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients
Harland, R.C.; Vernon, W.B.; Bunzendahl, H.; Thompson, J.K.; Lawrence, C.; Bollinger, R.R.
Transplantation Proceedings 26(2): 432-433
1994
ISSN/ISBN: 0041-1345 PMID: 8171488 Document Number: 436976
Document emailed within 1 workday
Related Documents
Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Dreikorn, K.; Doerr, H.W.; Geursen, R.G. 1985: Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG Scandinavian Journal of Urology and Nephrology. Supplementum 92: 15-21
Shen, G.K.; Alfrey, E.J.; Knoppel, C.L.; Dafoe, D.C.; Scandling, J.D. 1997: Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation Transplantation 64(6): 931-933
Uber, L.; Cofer, J.; Baliga, P.; Rajagopalan, P.R. 1995: Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient Transplantation Proceedings 27(5 Suppl 1: 42-43
Razonable, R.R.; Paya, C.V. 2003: Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections Herpes: the Journal of the Ihmf 10(3): 60-65
Pollard, R.B.; Merigan, T.C. 1978: Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 241-245
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Baldwin, W.M.; van Es, A.; Valentijn, R.M.; van Gemert, G.W.; Daha, M.R.; Vanes, L.A. 1982: Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections Clinical and Experimental Immunology 50(3): 515-524
Tollemar, J.; Ericzon, B.G.; Holmberg, K.; Andersson, J. 1990: The incidence and diagnosis of invasive fungal infections in liver transplant recipients Transplantation Proceedings 22(1): 242-244
Horng, I.H.; Chen, M.S.; Lee, P.H.; Chen, Y.C.; Lee, C.S.; Hou, P.K. 1989: Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient Journal of the Formosan Medical Association 88(11-12): 1152-1155
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Stratta, R.; Shaefer, M.; Markin, R.; Bradshaw, K.; Donovan, J.; Wood, R.; Langnas, A.; Reed, E.; Woods, G.; Zetterman, R. 1991: Ganciclovir therapy for viral disease in liver transplant recipients Transplantation Proceedings 23(3): 1968
Tollemar, J.; Ringdén, O.; Andersson, S.; Sundberg, B.; Ljungman, P.; Tydén, G. 1993: Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplantation 12(6): 577-582
Gondo, H. 1998: Cytomegalovirus infection in transplant recipients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(1): 173-178
Jankowski, M.; Gut, W.; Nawrocka, E.; Gradowska, L.; Roncewicz, Z.; Rowińska, D. 1982: Cytomegalovirus antibodies in renal transplant recipients Acta Microbiologica Polonica 31(3-4): 279-285
Sivathasan, C.; Doraisingham, S.; Ling, A.E.; Ng, A.; Allen, D.M.; Tong, M.C. 1992: Is cytomegalovirus infection going to be a problem among heart transplant recipients in Singapore? Transplantation Proceedings 24(5): 2019-2021
Abdelfatah, A.; Ducloux, D.; Toubin, Gérard.; Motte, Gérard.; Alber, D.; Chalopin, J-Marc. 2002: Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients Transplantation 73(4): 663-665
Mourad, G.; Chong, G.; Pouliquen, M.; Ruiz, G.; Mandin, J.; Mion, C. 1984: Withdrawal of azathioprine and antilymphocyte globulins in kidney transplant recipients with cytomegalovirus Transplantation Proceedings 16(5): 1313-1315
Rymarz, A.; Durlik, M.; Rydzewski, A. 2009: Intravenous administration of N-acetylcysteine reduces plasma total homocysteine levels in renal transplant recipients Annals of Transplantation 14(4): 5-9